Alaethes Wealth’s MetLife MET Stock Holding History

Alaethes Wealth’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,000	Closed	-$70K	–	229
2022 Q1	$70K	Hold	1,000	–	–	0.04%	130
2021 Q4	$62K	Hold	1,000	–	–	0.04%	128
2021 Q3	$62K	Hold	1,000	–	–	0.05%	125
2021 Q2	$60K	Buy	+1,000	New	+$63.4K	0.05%	123

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Alaethes Wealth's MET Position: Q2 2022 in Review

Alaethes Wealth sold out of MetLife (MET) in Q2 2022, closing a stake of 1,000 shares — an estimated $70K sold.

Alaethes Wealth first reported a position in MET in Q2 2021 and held it in 4 quarters. The position peaked at $70K in Q1 2022. 1,198 funds tracked by Wall St. Rank hold MET as of Q2 2022.

Alaethes Wealth reported no remaining MetLife position as of Q2 2022 after selling out during the quarter.
Alaethes Wealth sold 1,000 MetLife shares in Q2 2022, an estimated $70K.
Alaethes Wealth first reported a position in MetLife in Q2 2021 and held it in 4 quarters.
Alaethes Wealth's MetLife position peaked at $70K in Q1 2022.
1,198 funds tracked by Wall St. Rank held MetLife as of Q2 2022.

Based on Alaethes Wealth's 13F filing for Q2 2022, filed 16 Aug 2022.